LABORATORY PRODUCTS
The specialised frontier: Why laboratory AI requires purpose-built platforms, not general-purpose tools
Avisikta Upadhyay, LabVantage Solutions
The laboratory informatics industry is rapidly evolving. However, due to data silos and manual documentation leading to slower innovations, the life sciences industry is facing challenges due to missing critical insights and lost productivity
The capability for average knowledge workers to leverage these tools, which effectively allow for instant access to a ‘polymath in a tab’ for summarising complex documents, drafting emails and debugging code, has changed dramatically. Additionally, for businesses, the versatility of these tools being ‘general-purpose’ is one of the primary benefits. However, as the digital transformation of life sciences and industrial R&D accelerates, a critical realisation is dawning on laboratory leaders: the lab is not a general-knowledge world.
Laboratory environments are highly regulated, precision- driven, and physically constrained ecosystems. In this high-stake arena, the ‘disconnected advisor’ model of consumer AI falls short. To maximise the usefulness of AI within research and diagnostics, we need to shift from creating generic AI solutions to creating specific laboratory AI platforms that are tailored towards understanding the subtleties inherent in using a pipette, conducting a compliance audit and managing the complexities associated with working in a sterile environment.
If we want to unlock the power of AI in scientific research and diagnostic processes, it is very important to be able to create new Lab-Specific AI Platforms for Research and Diagnostics.
The context gap:
Precision vs. probability At their core, general-purpose AI tools are static and operate on probability. They predict the next most likely token in a sequence based on a massive corpus of diverse data. While this produces impressive reasoning capabilities, it lacks ‘domain-specific awareness’. In a laboratory, the cost of a hallucination isn’t just a typo in a memo; it is a ruined batch, a failed clinical trial, or a safety violation.
Laboratories follow strict guidelines, including GxPs, and a variety of ISO standards. All activities are done following validated workflows. A General AI does not know or understand how data is organised within these guidelines or how a particular result compares to the historical trend of instrument calibration. It views a set of results as text to be summarised, rather than a data point in a complex, multi-dimensional model of biological or chemical reality.
Without a deep understanding of the underlying science and the regulatory ‘moat’ surrounding it, general AI remains an outsider.
It can discuss the theory of chromatography, but it cannot verify if the specific peak integration on a chromatogram yesterday meets the internal quality control standards of a specific lab.
The integration imperative: Beyond the disconnected advisor
One of the most significant barriers to the utility of general AI in the lab is the lack of integration. Modern labs are powered by a trio of essential systems: Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELNs), and Instrument Control Systems. These are the ‘nervous system’ of the lab.
General-purpose tools ‘exist in a vacuum’. When a researcher uses a third-party chatbot to help interpret data, they are forced to manually export, de-identify, and upload that data. This creates a fragmented workflow where the AI acts as a disconnected advisor.
It can offer suggestions, but it cannot execute. It cannot trigger a re-test in the LIMS, it cannot automatically update an ELN entry, and it cannot monitor an incubator’s temperature in real-time.
A purpose-built lab AI doesn’t just sit on the sidelines watching you work; it rolls up its sleeves and joins you. Because it’s deeply woven into your LIMS, it already ‘speaks the language’ of your data. It knows your lab’s history and handles the documentation in real-time, so you don’t have to.
This changes AI from a tool you have to manage into a partner that frees you up to focus on science, not the paperwork.
Security, privacy, and the IP fortress
In the competitive world of drug discovery and materials science, intellectual property (IP) is the primary currency. General-purpose AI models present a terrifying security profile for many lab directors. When data is sent to an external, third-party AI, it often exits the organisation’s sphere of control.
There are three primary risks here: residency, auditability, and exposure.
• Residency: Where does the data live once it’s uploaded? For regulated labs, data must often stay within specific geographic or sovereign boundaries.
• Auditability: Regulators require a ‘chain of custody’ for data. General AI tools rarely provide the granular logs needed to prove who saw what data and how that data influenced a specific conclusion.
• Exposure: The most significant fear is that proprietary formulations or experimental results could inadvertently be incorporated into the AI’s training set, potentially leaking trade secrets to competitors who ask the right questions.
Laboratory AI requires a high degree of trust. It necessitates platforms where the models are brought to the data, not the other way around. Purpose-built platforms offer private instances, ensuring that sensitive data remains isolated and that the AI’s ‘learning’ is confined to the organisation’s secure environment.
Enterprise Requirements:
At their core, general-purpose AI tools are static and operate on probability
32
Multi-Tenancy and Elasticity For a global enterprise, the requirements for an AI platform are even more stringent. A lab AI cannot be a monolithic ‘one-size-fits-all’ installation. It must support multi-tenancy and lifecycle independence.
INTERNATIONAL LABMATE - FEBRUARY 2026
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
